•
Dec 31, 2022

Immix Biopharma Q4 2022 Earnings Report

Total Revenue
-$89.5M
EPS
-$0.27
Previous year: -$6.16
-95.6%
Gross Profit
-$89.5M
Cash and Equivalents
$13.4M
Previous year: $17.6M
-23.8%
Total Assets
$14.9M
Previous year: $18.2M
-18.1%

Immix Biopharma

Immix Biopharma